Cargando…

Efficacy of l‐Arginine treatment in patients with HTLV‐1‐associated neurological disease

OBJECTIVE: HTLV‐1 infection causes HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP), resulting in loss of motor function. In this Phase 2 trial, we assessed the efficacy and safety of l‐arginine in patients with HAM/TSP. METHODS: This open‐label, single‐arm, Phase 2 study enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nozuma, Satoshi, Matsuura, Eiji, Tashiro, Yuichi, Nagata, Ryusei, Ando, Masahiro, Hiramatsu, Yu, Higuchi, Yujiro, Sakiyama, Yusuke, Hashiguchi, Akihiro, Michizono, Kumiko, Higashi, Keiko, Matsuzaki, Toshio, Kodama, Daisuke, Tanaka, Masakazu, Yamano, Yoshihisa, Moritoyo, Takashi, Kubota, Ryuji, Takashima, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930431/ https://www.ncbi.nlm.nih.gov/pubmed/36547017 http://dx.doi.org/10.1002/acn3.51715

Ejemplares similares

Anti-ganglionic acetylcholine receptor antibodies in functional neurological symptom disorder/conversion disorder
por: Nagata, Ryusei, et al.
Publicado: (2023)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2017)

Anti-Human T-Cell Leukemia Virus Type 1 (HTLV-1) Antibody Assays in Cerebrospinal Fluid for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Kodama, Daisuke, et al.
Publicado: (2021)

Identification and tracking of HTLV-1–infected T cell clones in virus-associated neurologic disease
por: Nozuma, Satoshi, et al.
Publicado: (2023)

Inflammation with HTLV-1-specific CTLs occurs in the spinal cord of HTLV-1 carriers and the brain of the patients with HAM/TSP
por: Matsuura, Eiji, et al.
Publicado: (2014)

Iliopsoas Muscle Weakness as a Key Diagnostic Marker in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Matsuura, Eiji, et al.
Publicado: (2023)

Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2014)

HTLV-1-associated myelopathy/tropical spastic paraplegia with sporadic late-onset nemaline myopathy: a case report
por: Matsuura, Eiji, et al.
Publicado: (2023)

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2016)

Clinical presentation of axial myopathy in two siblings with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Matsuura, Eiji, et al.
Publicado: (2015)

Analysis of the association between the sex and disease courses of 132 consequent patients with HTLV-1-associated myelopathy/Tropic spastic paraparesis (HAM/TSP)
por: Matsuura, Eiji, et al.
Publicado: (2015)

Histopathologic differences between human T-lymphotropic virus type 1 (HTLV-1)-positive and HTLV-1-negative polymyositis
por: Abdullah, Hazem M, et al.
Publicado: (2011)

Genetic and clinical features of cerebellar ataxia with RFC1 biallelic repeat expansions in Japan
por: Ando, Masahiro, et al.
Publicado: (2022)

New type of encephalomyelitis responsive to trimethoprim/sulfamethoxazole treatment in Japan
por: Sakiyama, Yusuke, et al.
Publicado: (2015)

Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kodama, Daisuke, et al.
Publicado: (2020)

Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2020)

Cryptococcus Meningitis Can Co-occur with Anti-NMDA Receptor Encephalitis
por: Sakiyama, Yusuke, et al.
Publicado: (2020)

Prevalence of Fragile X-Associated Tremor/Ataxia Syndrome in Patients with Cerebellar Ataxia in Japan
por: Higuchi, Yujiro, et al.
Publicado: (2021)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

HTLV-1 infected CD4+T cells of HAM/TSP patients are susceptible to tunicamycin-induced endoplasmic reticulum stress
por: Kodama, Daisuke, et al.
Publicado: (2015)

Molecular and clinical analyses of HTLV-1 subgroups associated with the risk of developing HAM/TSP.
por: Saito, Mineki, et al.
Publicado: (2015)

Gene panel analysis of 119 index patients with suspected periodic paralysis in Japan
por: Yuan, Jun-Hui, et al.
Publicado: (2023)

Clinical features of familial HAM/TSP
por: Nozuma, Satoshi, et al.
Publicado: (2014)

Visualization of HTLV-1–Specific Cytotoxic T Lymphocytes in the Spinal Cords of Patients With HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
por: Matsuura, Eiji, et al.
Publicado: (2015)

HLA-A24-restricted HTLV-I-specific CTL response reduces the HTLV-I proviral load but the HLA increases the risk of HAM/TSP
por: Kubota, Ryuji, et al.
Publicado: (2011)

Genome wide association study of HTLV-1–associated myelopathy/tropical spastic paraparesis in the Japanese population
por: Penova, Marina, et al.
Publicado: (2021)

Reduced Tim-3 expression on HTLV-I Tax-specific cytotoxic T lymphocytes in HTLV-I infection
por: Abdelbary, Nashwa H, et al.
Publicado: (2011)

Possibility of γδ T cell immunotherapy for HTLV-1-infected individuals
por: Sato, Tomoo, et al.
Publicado: (2011)

The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice
por: Saito, Mineki, et al.
Publicado: (2014)

Multi-type RFC1 repeat expansions as the most common cause of hereditary sensory and autonomic neuropathy
por: Yuan, Jun-Hui, et al.
Publicado: (2022)

Neural bystander damage by infiltrating virus-infected T cells and the cytotoxic T lymphocytes in HTLV-I-associated neurological disease
por: Matsuura, Eiji, et al.
Publicado: (2011)

A new phenotype of mitochondrial disease characterized by familial late-onset predominant axial myopathy and encephalopathy
por: Sakiyama, Yusuke, et al.
Publicado: (2011)

Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease
por: Araya, Natsumi, et al.
Publicado: (2011)

Peripheral neuropathy in a case with CADASIL: a case report
por: Sakiyama, Yusuke, et al.
Publicado: (2018)

Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report
por: Terada, Yukiko, et al.
Publicado: (2017)

Updates on HTLV-1 Uveitis
por: Kamoi, Koju, et al.
Publicado: (2022)

The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP
por: Araya, Natsumi, et al.
Publicado: (2011)

Novel de novo POLR3B mutations responsible for demyelinating Charcot–Marie–Tooth disease in Japan
por: Ando, Masahiro, et al.
Publicado: (2022)

Biomarker to predict treatment response in patients with HTLV-1 associated myelopathy/Tropical spastic paraparesis (HAM/TSP)
por: Tamaki, Keiko, et al.
Publicado: (2015)

Comprehensive Genetic Analyses of Inherited Peripheral Neuropathies in Japan: Making Early Diagnosis Possible
por: Ando, Masahiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_atmlslf15qinvmvm763db7k8a4